Latest news
Price to book forward of Revelation Biosciences, Inc. – NASDAQ:REVBW - TradingViewTradingView · Sat, 08 Aug 2026 19:06:01 GMTRevelation Biosciences reports $3.3M net loss for Q2 2026, $11.5M cash on hand - TradingViewTradingView · Thu, 06 Aug 2026 20:35:16 GMTRevelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026 - Eagle-TribuneEagle-Tribune · Thu, 06 Aug 2026 20:16:44 GMTBRIEF-Revelation Biosciences Inc Q2 EPS USD -0.87 - TradingViewTradingView · Thu, 06 Aug 2026 20:16:01 GMTRevelation aims to start kidney injury trial enrollment by year-end - Stock TitanStock Titan · Thu, 06 Aug 2026 20:15:00 GMTREVELATION BIOSCIENCES 2Q 2026: Net loss $(3.32M), EPS $(0.87) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTRevelation Biosciences (Nasdaq: REVB) posts Q2 loss and flags cash risk - Stock TitanStock Titan · Thu, 06 Aug 2026 20:09:05 GMTREVB Q2'26 Earnings: EPS estimate is (0.83) USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:38 GMT